Cellebrite DI vs Yext
Cellebrite DI and Yext are similar in size: $476m and $447m of revenue in their latest fiscal years. Cellebrite DI grew faster (18.6% against 6.1%). Cellebrite DI kept more of each dollar of sales as profit: a net margin of 16.5% against 8.5%.
| Latest fiscal year | Cellebrite DICLBT, 2025 | YextYEXT, 2026 |
|---|---|---|
| Revenue | $476m | $447m |
| Revenue growth | 18.6% | 6.1% |
| Net income | $78.3m | $37.9m |
| Operating margin | 14.0% | — |
| Net margin | 16.5% | 8.5% |
| Return on equity | 19.1% | 24.2% |
| Free cash flow | $160m | $53.3m |
| Cash | $124m | $154m |
| Total debt | $0 | $98.0m |
| Debt to equity | 0.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | $67.4m |
| Employees | — | 1,120 |
| Market value | $3.03bn | $751m |
| Price vs our value range | Below our value range | Above our value range |
| Moat score | — | 28 (Weak) |
| Insider trades, 12 months | 0 buys, 15 sales | 2 buys, 5 sales |